LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis early-stage trial tests a combination of two drugs, cyclophosphamide and veliparib, in 35 people with HER2-negative breast cancer that has spread or cannot be removed by surgery. The goal is to find the safest dose and see how well the drugs work together to stop tumor growt…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy shows promise for hard-to-treat breast cancer
Disease control OngoingThis study tests whether a drug called olaparib, which blocks cancer cells from repairing themselves, works better alone or when combined with an immunotherapy drug (atezolizumab) for people with advanced breast cancer that has a specific genetic change (BRCA mutation). About 81 …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:18 UTC